<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
	<title>Inhibitors of mitosis - Colchicum, Catharanthus, Taxus; intercalation agents and</title>
	<meta name='Generator' content='Zim 0.73.1'>
	<style type='text/css'>
		a          { text-decoration: none      }
		a:hover    { text-decoration: underline }
		a:active   { text-decoration: underline }
		strike     { color: grey                }
		u          { text-decoration: none;
					 background-color: yellow   }
		tt         { color: #2e3436;            }
		pre        { color: #2e3436;
					 margin-left: 20px          }
		h1         { text-decoration: underline;
					 color: #4e9a06; margin-bottom: 0 }
		h2         { color: #4e9a06; margin-bottom: 0 }
		h3         { color: #4e9a06; margin-bottom: 0 }
		h4         { color: #4e9a06; margin-bottom: 0 }
		h5         { color: #4e9a06; margin-bottom: 0 }
		p          { margin-top: 0              }
		span.zim-tag {
			color: #ce5c00;
		}
		div.zim-object {
			border-style:solid;
			border-width:1px;
		}
		.checked-box {list-style-image: url(data:image/png;base64,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)}
		.xchecked-box {list-style-image: url(data:image/png;base64,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)}
		.unchecked-box {list-style-image: url(data:image/png;base64,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)}
		.migrated-box {list-style-image: url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAABGdBTUEAALGPC/xhBQAAAAZiS0dEAP8A/wD/oL2nkwAAAAlwSFlzAAANOgAADMQBiN+4gQAAAAd0SU1FB+AKHREFA8vJSnkAAAAZdEVYdENvbW1lbnQAQ3JlYXRlZCB3aXRoIEdJTVBXgQ4XAAAC1klEQVRIx+2VT0hUURTGf/e958w4Tc3TYowMw1GyEgwr1MqsFmbZIrIWQZsWJUjbdoHQpl3Qps0swnCRECQFYkR/TC1iKkqmfzAKTo2Vf8hoRsfR995tkRMT87RRWkUHHhy495zvnvvu933wP/75EKkkEAjIYDCIaZpIKRFCZN0kfX9xcTGtra2/irVUEolECIfDlJeXo+s6hmFkDaCqKoZhEAqFSCaTv60pqcSyLAoLC/F4PEtqDmCaJkIIKisrMybX0sdUVRWA5ubmPzdNjjI1cpXkZC/O1fV03PXgdDqRUtpPIITAsqxsDz0Z/3CZQv8uqo4N4C8/Tp2/DdM0MiZQlvk41OTkI/LW1SGtCVb5drD3eCc71wcA+VcAHA5vDd8+3UGakxiJV7i9pdQevU5T1R35pJ3MV5QW1pf+0kWBheJ2SWua8EQXZXsu4fVVYEz1sEKvof5EuxjoPvzpcRvrdp9C2gGMx6cpOHBmbImMesds7BZubwMVDTfXDnQ3vQfK7AC8wLfExMX5whyQc3q2OEnjGm5vE76SQxsfBLr77a7CNf+n0r/l6sSMtsBSnurckiIILCobAtVZhpF4gZF4jubaymj4Ch/fd380LE7bAnjc0NPxk2yqpmEuwGxF0ag+0k5uTpzZeBeaazvj0We8fXojainsb2xh2BZgbe0gSIllzSIUh63wfQ6dZ/O2fbjcKlOj58jJ3cVENESw5yErc9nf2MLQ4jwQAkV1Lqiq37/cZ9WaahJjF9AcmxiPDhLs7ePe23oOnmUwg2hSShQle96tKDjA2HAniusgo9FxnvY9Jxw7RWzGYy92QghM00x5g53qp9sHmtB58/o2umOI2NwGolMnMYUHIb7aAyiKwsjICLqu2/qBEIKUUAohMaSHSLyBSMoPTINQ6CX5+fn2AEVFRZSUlBCPx4nFYhl3L4RESjF/GEgX3pSj+Xw+/H7/b3U/AEOZFnp7O5+5AAAAAElFTkSuQmCC)}
		ul {list-style-image: none}
		/* ul rule needed to reset style for sub-bullets */
	</style>
</head>
<body>

<!-- Header -->
<div class='header'>
	[ <a href='./NorthAmerica.html'>Prev</a> ]

	[ <span class='insen'>Index</span> ]

	[ <a href='./Pharmacology.html'>Next</a> ]
</div>

<hr />

<!-- Wiki content -->

<div class='pages'>
	<div class='heading'>
	<h1>Inhibitors of mitosis - Colchicum, Catharanthus, Taxus; intercalation agents and <a name='20:Pharmacognosy'></a></h1>
	</div>

	<div class='content'>
	
<br>
<br>
<br>

<h1>inhibitors of topoisomerase - camptothecines, epipodophyllotoxin</h1>

<br>

<h1>Mitosis inhibitors</h1>

<br>

<h1>Catharanthus</h1>

<br>

<p>
→ Magadascar periwinkle  		[but now is also common in tropics]<br>
<ul style='padding-left: 30pt'>
<li><i>Catharanthus roseus (= Vinca rosea ) - (Apocynaceae)</i></li>
</ul>
→ small herb or shurb <br>
<ul style='padding-left: 30pt'>
<li>shiny dark green leaves</li>
<li>pleasant five-lobed flowers</li>
</ul>
→ USA,Europe,India,Australia,South America<br>
→ first used in hypoglycemic activity  [although extracts did not affect sugar levels in rabbit blood]<br>
<ul style='padding-left: 30pt'>
<li>but depleted white blood cells (leukopenia)</li>
<li>anti-cancer potentnial</li>
</ul>
→ this function showed in the alkaloid function of the plant<br>
<ul style='padding-left: 30pt'>
<li>more than 150 alkaloids</li>
<li>pricnipally "terpenoid indole alkaloids"</li>
</ul>
→ dimeric indole alkaloid structures shown anti-tumor activity<br>
<ul style='padding-left: 30pt'>
<li>vinblastine</li>
<li>vinleurosine</li>
<li>vinrosidine</li>
<li>vincristrine</li>
</ul>
→ Alkaloids<br>
<ul style='padding-left: 30pt'>
<li>vinblastine</li>
<li>vincristine     proved to be extremely valuable drugs.</li>
</ul>
→Despite the minor difference in structure between those compounds <br>
<ul style='padding-left: 30pt'>
<li>differences exists in the spectrum of humman cancer.</li>
</ul>
→ Vinblastine<br>
<ul style='padding-left: 30pt'>
<li>treatment of Hodgkin's disease ( cancer affecting the lymph glands,spleen,liver</li>
</ul>
→ Vincristine<br>
<ul style='padding-left: 30pt'>
<li>superior antitumor activity compared with vinblastine but is more neurotoxic</li>
<li>clinically more important than vinblastine especially
<ul>
<li>of childhood leukaemia → high rate of remission</li>
</ul>
</li>
<li>and other conditions such as lymphomas,small-cell lung cancer, etc</li>
</ul>
→ form part of combination regimen with other anticancer drugs<br>
→ Vindesine<br>
<ul style='padding-left: 30pt'>
<li>semi-synthetic amide derivative of vinblastine
<ul>
<li>acute=lymphoid leukaemia in children</li>
</ul></li>
</ul>
→ Vinorebline<br>
<ul style='padding-left: 30pt'>
<li>newer semi-synthetic modification obtained from
<ul>
<li>anhydrovinblastine</li>
</ul></li>
</ul>
→ orally active <br>
<ul style='padding-left: 30pt'>
<li>lower neurotoxic side-effects	 than either vinblastine or vincristine</li>
<li>advanced breat-cancer</li>
<li>non-small-lung cancer</li>
</ul>
</p>

<p>
⇒ This compounds ALL INHIBIT<br>
<ul style='padding-left: 30pt'>
<li>cell mitosis → acting by binding to the protein tubulin in the mitotic spindle
<ul>
<li>preventing polymerization into microtubules</li>
</ul>
</li>
<li>a mode shares also with other natural agents (e.g. // colchine , podophytlotoxin)</li>
</ul>
</p>

<p>
→ MAJOR PROBLEM<br>
<ul style='padding-left: 30pt'>
<li>only very small amounts of these desirable alkaloids are present in the plant</li>
</ul>
→ total alkaloids content of the leaf<br>
<ul style='padding-left: 30pt'>
<li>can reach 1% or more
<ul>
<li>which means 500kg of catharanthus is needed to yiled 1g of vincristine</li>
</ul></li>
</ul>
→ Extraction is both costly and tedious<br>
<ul style='padding-left: 30pt'>
<li>large amounts of raw materials and use of chromatographic fractionantions.</li>
</ul>
→ plant also produce much higher proportion of vinblastine than vicristine<br>
<ul style='padding-left: 30pt'>
<li>the latter is more medicinally more valuable.	
<ul>
<li>fortunately we can convert vinblastine to vincristin by chromid acid oxidation</li>
</ul></li>
</ul>
→ Catharanthus roseus produce much more higher amounts of <br>
<ul style='padding-left: 30pt'>
<li>catharanthine and vindoline
<ul>
<li>those two can be converted to vinblastin in about 40% yiled.</li>
</ul></li>
</ul>
</p>

<h1>Colchicum</h1>

<p>
→ seed and corn <br>
<ul style='padding-left: 30pt'>
<li>obtained from Colchicum autumnale (Liliaceae/Colchicaceae)
<ul>
<li>autumn crocus and meadow saffron</li>
</ul>
</li>
<li>thouogh is not crocus but produces crocus-like flowers in the autumn</li>
<li>native in Europe</li>
</ul>
→ principle alkaloid is <i>colchine</i><br>
<ul style='padding-left: 30pt'>
<li>about 0.8% in the seed and 0.6% in the corm</li>
<li>nitrogen is part of an amide functin 
<ul>
<li>does not display any significant basicity </li>
<li>does not form well-defined salts</li>
</ul></li>
</ul>
→ minor constituent<br>
<ul style='padding-left: 30pt'>
<li><i>Demecolcine</i>
<ul>
<li>which impaired purine metabolism → build up of uric acid in the joint.</li>
</ul></li>
</ul>
→ Cytotoxic properties<br>
<ul style='padding-left: 30pt'>
<li>potential anticancer agent</li>
<li>bind to tubulin in the mitotic spidnle,polymerization and assembly into microtubules</li>
</ul>
<ul>
<li>the feature of colchine's structure
<ul>
<li>two aromatmic rings are not </li>
<li>coplanar </li>
<li>twisted relative to each other with dihedral angle of 54 degrees
<ul>
<li>essential binding to tubulin</li>
</ul></li>
</ul></li>
</ul>
</p>

<h1>Taxus brevifolia and Taxol (Paclitaxel)</h1>

<p>
→ name taxol given to a<br>
<ul style='padding-left: 30pt'>
<li>diterpene ester with anticacner properties 1971
<ul>
<li><i>Taxus brevifolia</i></li>
</ul>
</li>
<li>accordingly the generic name <i>Paclitaxel </i>has be assigned to the compoud and the literature now contain a mixture of both names</li>
</ul>
→ Anti-cancer drug <i>taxol</i><br>
<ul style='padding-left: 30pt'>
<li>extracted from the bark of the Pacific yew
<ul>
<li><i>Taxus brevifolia; Taxaceae</i>
<ul>
<li>a slow-growing shurb/tree
<ul>
<li>forests of northwest Canada,USA</li>
</ul></li>
</ul></li>
</ul>
</li>
<li>low amounts 0.01%-0.02%)</li>
<li>up to 0.033% of taxol has been recorded 	
<ul>
<li>leaves and twigs</li>
</ul>
</li>
<li>Bark from about three mature trees is required to provide 1g of taxol
<ul>
<li>and a course of treatment may need 2g of the drug</li>
<li>harvesting has been strictly regulated</li>
</ul></li>
</ul>
→ All parts of <i>T.brevifolia</i><br>
<ul style='padding-left: 30pt'>
<li>wide range of diterpenoid derivatives 
<ul>
<li>termed as "taxanes"</li>
</ul>
</li>
<li>toxic constituents found in other Taxus species
<ul>
<li><i>T.baccata</i></li>
</ul></li>
</ul>
→ small group of compounds possessing<br>
<ul style='padding-left: 30pt'>
<li>a 4 member oxetane ring and a complex ester side-chain.</li>
<li>antitumor activity</li>
</ul>
→ Taxane derivatives<br>
<ul style='padding-left: 30pt'>
<li>0.2% baccatin III</li>
<li>10-deacetyltaxol</li>
<li>10-deacetylbacccatin III</li>
<li>cephalomannine</li>
<li>10-deactylcephalomannine</li>
</ul>
→ baccatin III and 10-deacetylbaccatin III<br>
<ul style='padding-left: 30pt'>
<li>have been efficiently transformed into taxol.</li>
</ul>
MECHANISM OF ACTION[AND THE DIFFERENCE WITH CATHARANTHUS AND COLCICHUM]
</p>

<p>
→ act as an antimitotic<br>
<ul style='padding-left: 30pt'>
<li>by binding to microtubules
<ul>
<li>promoting their assembly from tubulin
<ul>
<li>stabilizing them against depolymerization during cell division</li>
</ul></li>
</ul>
</li>
<li>abnormal tubulin-microtuble equilibrium
<ul>
<li>distrupts the normal mitotic sindle apparatus
<ul>
<li>and blocks profilation.</li>
</ul></li>
</ul></li>
</ul>
→ similar target but has a different mode of action to other antimitotics.<br>
→ a second mode of action of taxos<br>
<ul style='padding-left: 30pt'>
<li>blocks the process of apoptosis which leading to cell death</li>
</ul>
</p>

<br>

<p>
ntercalation agents and
</p>

<h1>Intercalation agents and topoisomerase - camptothecines and epipodophyllotoxin</h1>

<br>

<h1>Camptothecin</h1>

<p>
→ Camptothecin derivatives are obtained by the Chineese tree<br>
<ul style='padding-left: 30pt'>
<li><i>Camptotheca acuminata Nyssaceae</i>
<ul>
<li>seeds 0.3% camptothecin</li>
<li>bark 0.2%
<ul>
<li>10-hydroxycamptothecin - (0.05%)
<ul>
<li>is more active than <i>camptothecin </i>
<ul>
<li>used for neck and head cancer in China</li>
</ul></li>
</ul></li>
</ul>
</li>
<li>leaves up to 0.4%</li>
</ul>
</li>
<li>found in Tibet and China</li>
</ul>
<div style='padding-left: 300pt'>
→ Other sources
</div>
<ul style='padding-left: 330pt'>
<li><i>Nothapodytes foetida Icacinaceae</i></li>
<li><i>Meriliodendron megacarpum «</i></li>
<li><i>and others</i></li>
</ul>
→ broad-spectrum anticancer activity<br>
<ul style='padding-left: 30pt'>
<li>toxicity and water solubility were problems</li>
</ul>
→ Semi-synthetic<br>
<ul style='padding-left: 30pt'>
<li>9-aminocamptothecin </li>
</ul>
<ul>
<li>and the water soluble derivatives
<ul>
<li><i>topotecan </i></li>
<li><i>irinotecan</i>
<ul>
<li>for ovarian cancer and colorectal cancer respectively</li>
</ul></li>
</ul></li>
</ul>
→ <i>Irinotecan </i><br>
<ul style='padding-left: 30pt'>
<li>is a carbamate pro drug of 10-hydroxy-7-ethylcamptothecin
<ul>
<li>which converted into the active drug by liver enzymes.</li>
</ul></li>
</ul>
MECHANISM OF ACTION<br>
→ these agents act by : <br>
<ul style='padding-left: 30pt'>
<li>inhibition of the enzyme <i>topoisomerase I 	</i>
<ul>
<li>which involved in DNA replication 
<ul>
<li>by binding to and stabilizing a covalent DNA-topoisomerase comlex</li>
</ul></li>
</ul></li>
</ul>
</p>

<p>
→ many analogs and pro-drugs have been synthesized<br>
<ul style='padding-left: 30pt'>
<li><i>belotecan introduced in Korea</i></li>
<li>silicon-containg <i>karenitecin </i>
<ul>
<li>reduced sensitivity to common tumour-mediated drug resistance.</li>
</ul></li>
</ul>
</p>

<h1>Podophyllum</h1>

<p>
→ dried rhizome and roots of   [which contain cytotoxic lignands and their glycosides]	<br>
<ul style='padding-left: 30pt'>
<li><i>Podophyllum hecandrum (Podophyllum emodi)</i>
<ul>
<li>found in India,China,Himalayas and yields the "indian podophyllum"</li>
<li>about 6-12% of resin containg 50-60% lignans
<ul>
<li><i>podophyllotoxin (4%)</i></li>
<li><i>4'-demethylpodophylloxtoxin (0.45%)</i></li>
</ul></li>
</ul>
</li>
<li><i>Podophyllum peltatum; Berberidaceae</i>
<ul>
<li><a href="./NorthAmerica.html" title="NorthAmerica" class="page">NorthAmerica</a></li>
<li>about 2-8% of resin with 14-18% of lignans
<ul>
<li><i>podophyllotoxin (0.25%)</i></li>
<li><i>β-pelatin(0.33%)</i></li>
<li><i>a-pelatin(0.25%)</i></li>
</ul></li>
</ul></li>
</ul>
→ both are <br>
<ul style='padding-left: 30pt'>
<li>large-leafed</li>
<li>perennial hers</li>
<li>with edible fruits</li>
<li>though other parts of the plant are toxic.</li>
</ul>
</p>

<p>
→ Preparations of <i>podophyllotoxin resin </i><br>
<ul style='padding-left: 30pt'>
<li>for warts or venereal wars ( pure podophyllotoxin)</li>
</ul>
→ antimitotic effect of podoph. and other lignans<br>
<ul style='padding-left: 30pt'>
<li>binding to the protein tubulin ,preventing polymerizaiton and assembly into tubules
<ul>
<li>during mitosis 
<ul>
<li>chromosomes separates with the assistance of microtubules	
<ul>
<li>after cell division microtubules tranfomred back to tubulin</li>
</ul></li>
</ul></li>
</ul></li>
</ul>
→ Podophyllotoxin and other lignands found to be unsuitable for anti-cancer treatment due ot <br>
<ul style='padding-left: 30pt'>
<li>toxic side-effects</li>
<li>but semi-synthetic derivatives are manufactures from natural podophyllotoxin.
<ul>
<li>which proven to have excellent antitummor agents</li>
</ul></li>
</ul>
→ <i>Etoposide and Teniposide</i><br>
<ul style='padding-left: 30pt'>
<li>modified forms (acetals) of the natural 4-demethylopodophyllotoxin glucoside</li>
</ul>
→ <i>Etoposide</i><br>
<ul style='padding-left: 30pt'>
<li>effective anticancer agent
<ul>
<li>treatment of small-cell lung cancer
<ul>
<li>testicular cancer</li>
<li>lymphomas</li>
</ul></li>
</ul>
</li>
<li>combination therapies</li>
<li>orally or iv</li>
<li>believed to inhibit strand-rejoining ability by stabilizing the topoisomerase II-DNA-complex.
<ul>
<li>leading to double-strand breaks and cell death</li>
</ul></li>
</ul>
→ <i>Etopophos</i><br>
<ul style='padding-left: 30pt'>
<li>a water-soluble pro-drug (etoposide-4'-phosphate)
<ul>
<li>efficiently converted into <i>etoposide </i>by phosphatase enzymes</li>
</ul></li>
</ul>
→ <i>Teniposide</i><br>
<ul style='padding-left: 30pt'>
<li>similar anticancer properties
<ul>
<li>though not as widely used as etoposide</li>
</ul>
</li>
<li>has value in paediatric neuroblastoma.</li>
</ul>
MECHANISM OF ACTION<br>
→ 4'-demethylopodophyllotoxin series of lignagns<br>
<ul style='padding-left: 30pt'>
<li>DO NOT act via  tubuling-bidnign mechanism as podophyllotoxin</li>
</ul>
 → drugs<br>
<ul style='padding-left: 30pt'>
<li>inhibit the enzyme <i>topoisomerase II</i>
<ul>
<li>preventing DNA synthesis and replication</li>
</ul>
</li>
<li>is also responsible for 
<ul>
<li>cleavage of the DNA strands during replication process
<ul>
<li>classified as I and II according to the ability to cleave one or both strands</li>
</ul></li>
</ul></li>
</ul>
</p>

<p>
→ Diphylleia (Berberidaceae)<br>
<ul style='padding-left: 30pt'>
<li>fungi isolated from the roots of podophyllum species</li>
<li>gene tranfer between the plant and the endophytic fungus</li>
<li>called Trametes hirsuta from rhizomes of Podophyllum hexandrum</li>
<li>alternative source to the plant material even though yields tends to be rather low.</li>
</ul>
</p>

	</div>

	<br />

	<div class='page-footer'>

	</div>

	

</div>

</body>
</html>
